Services Design Development Scientific Advice Project Management QA – Quality Assurance Monitoring Clinical Performance Data Management/eTrials Biostatistics Medical Writing Expert Statement Expertise Pharmacokinetics BA/BE Interactions Oncological trials Ophthalmological trials Inhalatives Transdermal Therapeutic Systems Children Sexual Hormones Therapeutic Expertise Clinical Development Phase I Phase II / Proof of Concept Phase III in OTC Phase III Non-Interventional Magnetic Marker Monitoring Medical Devices Nutrition Studies Clinical Pharmacology Unit Location Plan Capacity Technical Monitoring Ophthalmology Gynaecology Intensive Assessment Unit Clean Room Area Archive About Us Goals and Visions Our Experts Science Quality Library Presentations Library Publications Locations Career News 1st GBHI-Conference – Conference Report now available 3rd GBHI conference – program is online Who is a healthy subject? German Pharm-Tox Summit 2017 in Heidelberg 2nd part of Introductory Course in Exploratory Medicines Development scheduled for February 2017 Introductory Course in Exploratory Medicines Development – taking place in our offices in Oberursel! Probanden The SocraTec Family SocraTec C&S SocraMetrics Cooperations
Cough MCID Database Endpoint Non interventional Inspection Biometrics Hypothalamic Source Data Verification Creativity Ophthalmology Clinical Monitoring Local tolerability CDM OTC Early phase Informed Consent Procedure Immunogenicity Scientific advice Macular Patient recruitment FIM Legal Information Referral system COPD Axis Sore throat Recruitment rates Subcontractor qualification Patch Network Gynaecological trials Standardisation Scientific expertise GCP training Healthy subjects Statistical Analysis Plan Dry eye Clinical trials SOP based Children Sequential designs US FDA In vitro in vivo correlation Bioavailability Biosimilars Uveitis SDV Hormone replacement therapy Investigators brochure Pharmacokintetics MMM AGAH Allergy Transdermal therapeutic system CRA CRO Statistical services Asthma Phase IIb trials Ophthalmologist Training EMA Authorities Data management Spacious archive Female adolescents Contraception MDI Paediatricians Efficacy GCP Protocol development Absorption Ocular tolerability Legal representative Copyright Elpro DUS Anaesthesiologist IB Pituitary Feasibility Clinical pharmacology unit Phase IIa trials Common cold Dermal irritation Postmenopausal women Sensitisation trials GLP First in human IVIVC PAES Phase II Consultancy Bioequivalence Competence Rhine Main area Experience Pharmacology Patients ICF Adrenocortical ADAM Xerostomia TTS Biopharmaceutical Data Management Plan Drug Food Interaction CDASH Central surveillance system Pharmacodynamic studies Centralised procedure Dose linearity IMPD Steady state Highly variable drugs Ovulation inhibition DPI Oncology Clinical study HRT CRF Drug Drug Interaction SocraTec C&S CDISC Edema Pragmatism SAS Lung Dry powder inhaler HTA DDI Quality Management System Ophthalmological trials Product development Design development Phase I Clinical development program US CFR 21 Part 11 Phase I Unit Protocol Cardiovascular surveillance CDSIC NIS Statistical programming IEC Sample size estimation Expert Oncological patients Inhalatives PASS Post authorisation Charcoal Thuringia Phase IV Life cycle management Metered dose inhaler Eye disease Pilot study FDA Degeneration Slit lamp microscopy Data Validation Plan Patch adhesion Quality Project Management Pharmacokinetics Absorption windows Glaucoma Good Clinical Practice Phase III Standard operating procedure Auditing WinNonlin ANVISA Monitoring Pulse oximetry plethysmography Biopharmaceutics Oncologic network Quality Assurance HPA axis Safety Audit Intensive assessment station DFI  
 
Menu

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
All fine on front page